SOUTHLAKE, Texas – September 20, 2021 – OncoNano Medicine, Inc. today announced an oral presentation...
Read More
July 19, 2021 SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced a presentation at the 2nd Annual LifeSci…
Financing round led by Advantech healthcare investment team Funds will support Phase 3 program for…
SOUTHLAKE, Texas – August 27, 2019 – OncoNano Medicine, Inc. today announced that it has…
Southlake, TX. – June 26, 2020 – OncoNano Medicine, Inc. announced today the publication of…
– UTSW scientists demonstrate that a novel pH-sensitive polymer prolongs STING-mediated activation of innate immunity against…
- UTSW scientists demonstrate that a novel pH-sensitive polymer prolongs STINGmediated activation of innate immunity...
Read More
Mr. Driscoll’s deep experience in the biopharmaceutical industry particularly the immuneoncology field makes him ideally...
Read More
Findings indicate proof of mechanism and strong antitumor efficacy in preclinical models SOUTHLAKE, Texas –...
Read More
Findings indicate favorable tolerability and proof of mechanism in various solid tumors SOUTHLAKE, Texas –...
Read More